2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow URC102: new trials by email Literature Review of URC102 trials Research Report on URC102
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of URC102 to Assess the Safety and Efficacy in Gout Patients URC102, Placebo - Gout, Hyperuricemia | Phase 2 | Completed | JW Pharmaceutical | 76 | 2015-10-01 | 2017-01-10 |
| Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients URC102 0.25mg, URC102 0.5mg, URC102 1.0mg - Gout, Hyperuricemia | Phase 2 | Completed | JW Pharmaceutical | 64 | 2014-07-24 | 2017-03-08 |
Gout (2) · Hyperuricemia (2)
South Korea (2)